Minicozzi Velia, Giuliani Alessandro, Mei Giampiero, Domenichelli Leonardo, Parise Mauro, Di Venere Almerinda, Di Paola Luisa
INFN and Department of Physics, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Molecules. 2025 Mar 22;30(7):1412. doi: 10.3390/molecules30071412.
The molecular approach to understanding the mechanisms of emerging diseases, like COVID-19, has largely accelerated the search for successful therapeutical strategies. In this work, we present an extensive molecular dynamics (MD) analysis of two forms of the SARS-CoV-2 main protease M. We analyzed the free form (apo) and compared the results with those coming from the (holo) form bound to the inhibitor Boceprevir, an FDA-approved drug repurposed for COVID-19 therapy. We applied Dynamic Cross Correlation (DCC) analysis to the MD simulations to trace the concerted motion patterns within the protein structure. Although symmetric, the homodimer in the bound form showed clearly asymmetric dynamical behavior. In particular, the presence of concerted motions was detected in the protomer where the expulsion of the substrate from the active site happened. Such behavior was not observed in the same time lapses in the apo form. These results highlight a sort of 'symmetry breaking', making a symmetric structure to display functional induced asymmetric behavior in response to a perturbation. This highly coordinated dynamics in response to an external cue confirms the character of 'complex molecular machines' of biopolymers.
从分子层面理解诸如新冠病毒(COVID-19)等新兴疾病发病机制的方法,在很大程度上加速了对成功治疗策略的探索。在这项工作中,我们对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶M的两种形式进行了广泛的分子动力学(MD)分析。我们分析了其游离形式(无配体形式),并将结果与结合了抑制剂博赛泼维(Boceprevir)的(全酶形式)进行比较,博赛泼维是一种重新用于COVID-19治疗的美国食品药品监督管理局(FDA)批准的药物。我们将动态交叉相关(DCC)分析应用于MD模拟,以追踪蛋白质结构内的协同运动模式。虽然是对称的,但结合形式的同二聚体表现出明显的不对称动力学行为。特别是,在底物从活性位点排出的原体中检测到了协同运动。在相同时间间隔内,无配体形式未观察到这种行为。这些结果突出了一种“对称性破缺”,使对称结构在受到扰动时表现出功能性诱导的不对称行为。这种响应外部线索的高度协调动力学证实了生物聚合物“复杂分子机器”的特性。